197 related articles for article (PubMed ID: 25503463)
1. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia.
Tuhan HU; Catli G; Anik A; Onay H; Dundar B; Bober E; Abaci A
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):701-4. PubMed ID: 25503463
[TBL] [Abstract][Full Text] [Related]
2. High aldosterone and cortisol levels in salt wasting congenital adrenal hyperplasia: a clinical conundrum.
Boddu SK; Madhavan S
J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1327-1331. PubMed ID: 29127765
[TBL] [Abstract][Full Text] [Related]
3. Pseudohypoaldosteronism without nephropathy masking salt-wasting congenital adrenal hyperplasia genetically confirmed.
Balcells C; Gili T; Pérez J; Corripio R
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23370958
[TBL] [Abstract][Full Text] [Related]
4. Does pseudohypoaldosteronism mask the diagnosis of congenital adrenal hyperplasia?
Ağladıoğlu SY; Aycan Z; Kendirci HN; Erkek N; Baş VN
J Clin Res Pediatr Endocrinol; 2011; 3(4):219-21. PubMed ID: 22155467
[TBL] [Abstract][Full Text] [Related]
5. [Congenital adrenal hyperplasia].
Stanić M; Nesović M
Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
[TBL] [Abstract][Full Text] [Related]
6. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
Dörr HG; Sippell WG
J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
[TBL] [Abstract][Full Text] [Related]
7. Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
Abdalla A; Alhassan MA; Tawfeeg R; Sanad A; Tawamie H; Abdullah M
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34165441
[TBL] [Abstract][Full Text] [Related]
8. Failure to thrive, hyponatremia, and hyperkalemia in a neonate.
Sopfe J; Simmons JH
Pediatr Ann; 2013 May; 42(5):74-9. PubMed ID: 23641881
[TBL] [Abstract][Full Text] [Related]
9. Difficulties in the diagnosis and management of eight infants with secondary pseudohypoaldosteronism.
Günay F; Şıklar Z; Berberoğlu M
Turk J Pediatr; 2022; 64(3):490-499. PubMed ID: 35899562
[TBL] [Abstract][Full Text] [Related]
10. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
[TBL] [Abstract][Full Text] [Related]
11. Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience.
Bizzarri C; Olivini N; Pedicelli S; Marini R; Giannone G; Cambiaso P; Cappa M
Ital J Pediatr; 2016 Aug; 42(1):73. PubMed ID: 27485500
[TBL] [Abstract][Full Text] [Related]
12. On the prenatal diagnosis of congenital adrenal hyperplasia (CAH) by measurement of amniotic fluid 17-alpha-hydroxyprogesterone, aldosterone and cortisol.
Grankvist K; Bäckström BT; Gustavsson G; Holmgren G
Acta Obstet Gynecol Scand; 1989; 68(1):71-4. PubMed ID: 2801032
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone signaling defect in young infants: single-center report and review.
Wijaya M; Ma H; Zhang J; Du M; Li Y; Chen Q; Guo S
BMC Endocr Disord; 2021 Jul; 21(1):149. PubMed ID: 34243750
[TBL] [Abstract][Full Text] [Related]
14. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase.
Speiser PW; Agdere L; Ueshiba H; White PC; New MI
N Engl J Med; 1991 Jan; 324(3):145-9. PubMed ID: 1984191
[TBL] [Abstract][Full Text] [Related]
16. Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia.
Attia NA; Marzouk YI
Case Rep Endocrinol; 2016; 2016():6384697. PubMed ID: 26904317
[TBL] [Abstract][Full Text] [Related]
17. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
[TBL] [Abstract][Full Text] [Related]
18. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.
Kuhnle U; Chow D; Rapaport R; Pang S; Levine LS; New MI
J Clin Endocrinol Metab; 1981 Mar; 52(3):534-44. PubMed ID: 6257750
[TBL] [Abstract][Full Text] [Related]
19. Presenting status of children with classical congenital adrenal hyperplasia over two decades (1999-2018) in the absence of newborn screening in Sri Lanka.
Seneviratne SN; Sandakelum U; Jayawardena CH; Weerasinghe AM; Wickramarachchi PS; de Silva S
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1131-1137. PubMed ID: 34192833
[TBL] [Abstract][Full Text] [Related]
20. Salt losing nephropathy simulating congenital adrenal hyperplasia in an infant.
Kari JA; Bamashmous HA; Al-Agha AE; Mosli HA
Saudi Med J; 2002 Jul; 23(7):863-5. PubMed ID: 12174243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
